Blue Water Ventures International, Inc. BWVI
0.00 USD 0.00 (+0.00%)
At closeNov 10, 2026, 4:00 PM EST
0.0003 Day range 0.0003
0.0001 52-week range 0.0153
- YTD
- +600.00%
- 1 year
- +133.33%
News
accesswire.com Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences MIAMI, FL / ACCESSWIRE / May 16, 2024 / Psycheceutical Bioscience, Inc. ("Psycheceutical" or the "Company") (OTC PINK:BWVI), a bioscience company dedicated to developing cutting-edge technologies for…
accesswire.com Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space The distress in the psychedelic space contributed to the Company's challenges. The inability of the Company to undertake certain corporate actions (name and symbol change etc.
accesswire.com Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc. MIAMI, FL / ACCESSWIRE / December 12, 2023 / Psycheceutical Bioscience, Inc. ("Psycheceutical" or the "Company") (OTC PINK:BWVI), a bioscience company dedicated to developing cutting-edge…
accesswire.com Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD Company's novel NeuroDirectTM topical ketamine formulation to treat PTSD shown to be safe and well-tolerated in first cohort of Phase I trial. MIAMI, FL / ACCESSWIRE / August 10, 2023 /…
accesswire.com Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy Multi-year PCAOB audited financials completed Company on the path to become fully SEC reporting Future corporate action with name and symbol change MIAMI, FL / ACCESSWIRE / August 1, 2023 /…
accesswire.com First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD Psycheceutical's clinical trial program is the first ever to test the topical application of ketamine for use in treating a mental health disorder through the company's NeuroDirect™ delivery system.…benzinga.com Stocks That Hit 52-Week Lows On Friday
